Pain Management Devices Market Size, Share & Trends Analysis Report By Type (Neuromodulation and neurostimulation devices, Analgesic infusion pumps, Ablation devices), By Applications (Cancer pain, Neuropathic pain, Facial and migraine pain, Musculoskeletal pain, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Pain Management Devices Market Size

The global pain management devices market size was valued at USD 4.86 billion in 2025 and is projected to grow from USD 5.14 billion in 2026 to USD 8.00 billion by 2034, registering a CAGR of 5.7% during the forecast period from 2026 to 2034. North America dominated the pain management devices market with a market share of 39.2% in 2025.

The increase in the prevalence of chronic diseases and the rise in the geriatric population is expected to drive the need for pain management devices to treat chronic pain, thereby boosting the pain management devices market's growth.

Medical devices and equipment used to treat and relieve chronic or acute pain are pain management devices. These devices include neuromodulation and neurostimulation devices, analgesic infusion pumps, and ablation devices, varying from basic portable devices to complex implants. These devices treat various illnesses in the worldwide market for pain management devices, including back, cancer, neuropathic, and musculoskeletal pain. They generally aim at people suffering from chronic pain and seek non-pharmacological options such as nerve stimulation and physical therapy.

Segmentation Analysis

By Type

The global market for pain management devices is bifurcated based on type into neuromodulation and neurostimulation devices, analgesic infusion pumps, and ablation devices.

The neuromodulation and neurostimulation devices segment dominates the global market and will likely exhibit a CAGR of 5.7% over the forecast period. Neurostimulation is the invasive or non-invasive process to control and alter neural activities for therapeutic applications. These devices are used for neurostimulation function by stimulating nerve impulses or inhibiting pain signals at target sites, such as the central, autonomic, peripheral, and others. The rise in demand for neuromodulation and neurostimulation devices, an increase in patient awareness toward neurostimulation devices for treating chronic pain, and the launch of innovative products drive the market growth of this segment. In addition, the rise in the prevalence of neurological disorders such as Parkinson's disease, migraine, and chronic pain with the surge in the adoption of neurostimulation and neuromodulation devices for pain management is expected to drive the market growth. Moreover, the increase in demand for safer, more effective, minimally invasive, and cost-effective treatments further supports the market growth. Key players such as Medtronic, Abbott Laboratories, and Boston Scientific Corp. operate in this market.

Request Customizationto receive a tailored report.

By Application

The global pain management devices market is bifurcated into cancer, neuropathic, facial and migraine, musculoskeletal pain, and others.

The neuropathic pain segment owns the global market and is predicted to exhibit a CAGR of 5.5% over the forecast period. Neuropathic pain is a persistent disorder caused by somatosensory nervous system injury or illness. Neuropathic pain does not appear suddenly or disappear fast; it is a chronic illness that causes enduring pain. According to an article by O. van Hecke et al., about one in three Americans experience chronic pain. Of those, one in five experience neuropathic pain; as many as 10% of Americans experience some form of neuropathic pain. The surge in the target population, along with an increase in several risk factors such as diabetes, HIV, multiple sclerosis, and cancer, technological advancement in pain management devices, and a surge in demand for pain management devices for the management of neuropathic pain are the major factors that drive the market growth. Spinal cord stimulation, peripheral nerve stimulation, and analgesic pain pumps are widely used to treat neuropathic pain.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Dominant Region with 5.3% of the Market Share

North America is the most significant global pain management devices market shareholder and is estimated to grow at a CAGR of 5.3% over the forecast period. The U.S. is the largest revenue contributor in North America and a mature market. The presence of major key players in the region, such as Boston Scientific Corporation, Abbott Laboratories, and Johnson and Johnson, is a major factor contributing to the growth of the pain management devices industry. In addition, the increase in demand for muscle and nerve stimulators, the rise in prevalence of chronic pain, the surge in demand for pain management devices, the presence of advanced healthcare facilities with trained medical professionals, and a higher number of RandD activities to develop innovative devices significantly contribute toward the growth of the North America market. An increase in the prevalence of musculoskeletal disorders, such as osteoarthritis, arthritis, rheumatoid arthritis, and orthopedic degenerative disorders, and a resultant increase in cases of chronic pain boost product demand. Also, due to high awareness among the population regarding advanced pain management devices, increased adoption of pain management devices, supportive reimbursement policies, rise in the geriatric population, and availability of advanced devices in North America. Furthermore, the rise in government initiatives such as the Precision Medicine and Affordable Care Act, well-planned reimbursement scenarios, and a rise in pain management awareness supplement the market growth in North America.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Fastest Growing Region with the Highest CAGR

Europe will likely exhibit a CAGR of 5.7% over the forecast period. The Rise in demand for pain management devices, the strong presence of key players such as Medtronic Plc. and B. Braun Melsungen AG, and the increase in adoption of pain management devices positively impact the market growth in Europe. Moreover, the rise in the prevalence of neuropathic pain, the availability of developed infrastructure for pharmaceutical and medical devices, and the increase in the geriatric population are the other key growth drivers of the European market. The markets for pain management devices in Germany, France, and the UK are anticipated to exhibit significant growth due to the strong presence of key players, the availability of developed healthcare infrastructure, and technological innovations in pain management devices. The presence of developed infrastructure in the healthcare industry and the availability of trained professionals are the other key growth drivers of the European market.

The Asia-Pacific market will likely show the fastest market growth over the forecast period, owing to improvements in healthcare infrastructure, the availability of pain management devices, a surge in healthcare reforms, and technological advancements in the healthcare field. Furthermore, major manufacturers have been focused on extending their geographical presence in rising Asia-Pacific nations to capitalize on market development prospects. Furthermore, due to a huge patient population, a considerable surge in demand for modern medical facilities, and an increase in R&D efforts to create novel pain management devices, China is expected to expand at the quickest CAGR throughout the projected period.

LAMEA is in its nascent phase due to the lack of availability of trained medical professionals and medical device manufacturers. This is attributed to an increase in healthcare expenditure. In addition, the rise in government funding and the development of programs for healthcare awareness drive the market growth in LAMEA. Brazil was the major shareholder in LAMEA in 2020, accounting for about 31.06% share of the LAMEA pain management devices industry.

List of Key and Emerging Players in Pain Management Devices Market